Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about lymphoma Recent news which mentions lymphoma Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration May 01, 2023 Tickers BMY IMTX Tags Small Cap General Diseases From Benzinga Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus' Story December 08, 2022 Tags Gilead CAR T/cell Therapy Health & Healthcare From 3BL Media: Corporate Social Responsibility, Energy and Health News Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey April 20, 2022 Tags Gilead Health & Healthcare NYSE:GILD From 3BL Media: Corporate Social Responsibility, Energy and Health News Discover Cord Blood’s Life-Saving Benefits at the 7th Annual Arizona Cord Blood Conference – United by Our Strengths March 07, 2022 Tags be the match Cancer Research Stem Cells From PRUnderground Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma December 14, 2021 Tickers FATE Tags ASH21 Market News News From Benzinga Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients December 14, 2021 Tickers GILD Tags Phase 2 Trial General Benzinga From Benzinga Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation December 13, 2021 Tickers VIRX Tags Market News ASH21 Trading Ideas From Benzinga Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting December 13, 2021 Tickers JAZZ Tags ASH21 Market News News From Benzinga Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings December 13, 2021 Tickers RHHBF RHHBY RHHVF Tags Phase 2 Trial RHHBF General From Benzinga Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients December 13, 2021 Tickers GILD Tags News Health Care ASH21 From Benzinga Bristol Myers Reveals Full Data For Breyanzi In Second-Line Lymphoma Setting December 13, 2021 Tickers BMY Tags Biotech lymphoma Health Care From Benzinga TG Therapeutics Shares Plunge After FDA Plans AdComm Meet For Blood Cancer Candidate November 30, 2021 Tickers TGTX Tags Chronic Lymphocytic Leukemia Benzinga Movers From Benzinga Affimed's Lymphoma Candidate Shows 100% Objective Response Rate At Highest Dose November 22, 2021 Tickers AFMD Tags Phase 2 Trial General Small Cap From Benzinga Soligenix To File US Application For Its Lymphoma Photodynamic Therapy In 2H 2022 November 01, 2021 Tickers SNGX Tags lymphoma Biotech Benzinga From Benzinga IDI Consulting Supports the Leukemia & Lymphoma Society's Light The Night Walk October 25, 2021 Tags Light The Night Leukemia Non/profit From PRLog Gilead's Kite Files US Application To Expand Use Of Yescarta In Second-Line Setting October 01, 2021 Tickers GILD Tags Health Care Benzinga lymphoma From Benzinga BeiGene's Brukinsa Scores FDA Approval For Marginal Zone Lymphoma September 15, 2021 Tickers BGNE Tags Trading Ideas Health Care News From Benzinga Soligenix Stock Moves Higher On US Orphan Drug Tag For T-cell Lymphoma Candidate September 09, 2021 Tickers SNGX Tags Market News why it's moving SNGX From Benzinga ADC Therapeutics Announces $325M Financing Agreement With HealthCare Royalty August 26, 2021 Tickers ADCT Tags News Trading Ideas Health Care From Benzinga Fate Therapeutics' Stem Cell-Derived NK Lymphoma Candidate Casts Doubt Over Durability Of Response August 20, 2021 Tickers FATE Tags FATE General Movers From Benzinga Cellectar Receives $2M NIH Grant For Rare Lymphoma Study August 18, 2021 Tickers CLRB Tags News Health Care Penny Stocks From Benzinga F-star's FS118 Development Program To Include Checkpoint Naïve Cancer Patients August 12, 2021 Tickers FSTX Tags Market News News FSTX From Benzinga BeiGene's Brukinsa Scores Second Approval In Canada, This Time For Mantle Cell Lymphoma July 26, 2021 Tickers BGNE Tags General Health Canada FDA From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
